By Don Nico Forbes
Steris said the trial against its Isomedix subsidiary was dismissed and will be rescheduled for a later date.
The Irish medical-device company said the case, which began on Dec. 4, was declared a mistrial on Friday at the plaintiff's request after the dismissal of a juror reduced the jury to fewer than twelve.
The trial was set to address a claim that ethylene-oxide emissions from a sterilization facility in Waukegan, Illinois--which Isomedix owned and operated from 2005 to 2008--caused personal injury.
The Illinois court will schedule the case for retrial at a later date, the company said.
On Nov. 7, Steris disclosed that it was facing hundreds of lawsuits alleging harm arising from its use of ethylene oxide in the sterilization of medical devices.
"Isomedix intends to continue to vigorously defend against [the] allegations," it said.
Write to Don Nico Forbes at don.forbes@wsj.com
(END) Dow Jones Newswires
January 21, 2025 07:04 ET (12:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。